Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Annals of the New York Academy of Sciences|December 13, 2005
Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatmentSylvia T Singer, Frans A Kuypers, Nancy F Olivieri, et al.
Medical Oncology (Northwood, London, England)|July 6, 2016
Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generationMarcel H Fens, Pedro Cabrales, Jan Scicinski, et al.
Complementary Therapies in Medicine|July 17, 2022
The effects of glutamine supplementation on markers of apoptosis and autophagy in sickle cell disease peripheral blood mononuclear cellsPatrick B Walter, Leah S Hohman, Andrew Rokeby, et al.
Pediatric Blood & Cancer|May 29, 2023
Effect of voxelotor on cardiopulmonary testing in youths with sickle cell anemia in a pilot studyVivian Phan, Jared Hershenson, Laura Caldarera, et al.
Stem Cells Translational Medicine|December 1, 2012
Multipotent stromal stem cells from human placenta demonstrate high therapeutic potentialIgor Nazarov, Jae W Lee, Eric Soupene, et al.
The Journal of Biological Chemistry|July 6, 2023
Differential roles for ACBD4 and ACBD5 in peroxisome-ER interactions and lipid metabolismJoseph L Costello, Janet Koster, Beatriz S C Silva, et al.
Hemoglobin|June 27, 2006
Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndromeSamir K Ballas, Beatrice Files, Lori Luchtman-Jones, et al.
Haematologica|November 9, 2004
In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemiaLucia de Franceschi, Franco Turrini, Marek Honczarenko, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 13, 2021
Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C)Frans A Kuypers, Christina A Rostad, Evan J Anderson, et al.
Pageof 9